BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 32100085)

  • 1. [Chordoma: is there a molecular basis for diagnosis and treatment?].
    Scheipl S; Igrec J; Leithner A; Smolle M; Haybäck J; Liegl B
    Pathologe; 2020 Mar; 41(2):153-162. PubMed ID: 32100085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chordoma: the nonsarcoma primary bone tumor.
    Chugh R; Tawbi H; Lucas DR; Biermann JS; Schuetze SM; Baker LH
    Oncologist; 2007 Nov; 12(11):1344-50. PubMed ID: 18055855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chordomas].
    Riopel C; Michot C
    Ann Pathol; 2007 Feb; 27(1):6-15. PubMed ID: 17568354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chordoma: current concepts, management, and future directions.
    Walcott BP; Nahed BV; Mohyeldin A; Coumans JV; Kahle KT; Ferreira MJ
    Lancet Oncol; 2012 Feb; 13(2):e69-76. PubMed ID: 22300861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing an extra-axial chordoma of the proximal tibia with the help of brachyury, a molecule required for notochordal differentiation.
    O'donnell P; Tirabosco R; Vujovic S; Bartlett W; Briggs TW; Henderson S; Boshoff C; Flanagan AM
    Skeletal Radiol; 2007 Jan; 36(1):59-65. PubMed ID: 16810540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraosseous benign notochordal cell tumours: overlooked precursors of classic chordomas?
    Yamaguchi T; Suzuki S; Ishiiwa H; Ueda Y
    Histopathology; 2004 Jun; 44(6):597-602. PubMed ID: 15186275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of SMARCB1/INI1 expression in poorly differentiated chordomas.
    Mobley BC; McKenney JK; Bangs CD; Callahan K; Yeom KW; Schneppenheim R; Hayden MG; Cherry AM; Gokden M; Edwards MS; Fisher PG; Vogel H
    Acta Neuropathol; 2010 Dec; 120(6):745-53. PubMed ID: 21057957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chordoma.
    Ulici V; Hart J
    Arch Pathol Lab Med; 2022 Mar; 146(3):386-395. PubMed ID: 34319396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic features of four rare types of chordomas, confirmed by brachyury immunostaining.
    Rekhi B; Banerjee D; Ramadwar M; Bajpai J; Jambhekar NA
    Indian J Pathol Microbiol; 2017; 60(3):350-354. PubMed ID: 28937370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary tumor with notochordal differentiation: report of 2 cases suggestive of benign notochordal cell tumor of extraosseous origin.
    Kikuchi Y; Yamaguchi T; Kishi H; Azuhata K; Kimizuka G; Hiroshima K; Nakatani Y
    Am J Surg Pathol; 2011 Aug; 35(8):1158-64. PubMed ID: 21716081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Novel molecular aspects of chordomas].
    Scheil-Bertram S
    Pathologe; 2014 Nov; 35 Suppl 2():237-41. PubMed ID: 25394972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poorly differentiated chordoma: review of 53 cases.
    Yeter HG; Kosemehmetoglu K; Soylemezoglu F
    APMIS; 2019 Sep; 127(9):607-615. PubMed ID: 31243811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal chordomas dedifferentiated to osteosarcoma: a report of two cases and a literature review.
    Kato S; Gasbarrini A; Ghermandi R; Gambarotti M; Bandiera S
    Eur Spine J; 2016 May; 25 Suppl 1():251-6. PubMed ID: 27052403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extra-axial chordoma.
    DiFrancesco LM; Davanzo Castillo CA; Temple WJ
    Arch Pathol Lab Med; 2006 Dec; 130(12):1871-4. PubMed ID: 17149966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotypic features of dedifferentiated skull base chordoma: An insight into the intratumoural heterogeneity.
    Batista KMP; Reyes KYA; Lopez FP; Pelaz AC; Vega IF; Pendás JLL; Ayala AS; Astudillo A; Rojas JAN; Fernandez PB
    Contemp Oncol (Pozn); 2017; 21(4):267-273. PubMed ID: 29416431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poorly differentiated chordoma showing loss of SMARCB1/INI1: Clinicopathological and radiological spectrum of nine cases, including uncommon features of a relatively under-recognized entity.
    Rekhi B; Michal M; Ergen FB; Roy P; Puls F; Haugland HK; Soylemezoglu F; Kosemehmetoglu K
    Ann Diagn Pathol; 2021 Dec; 55():151809. PubMed ID: 34482218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and histopathologic features of chordomas in children and young adults.
    Ridenour RV; Ahrens WA; Folpe AL; Miller DV
    Pediatr Dev Pathol; 2010; 13(1):9-17. PubMed ID: 19348512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel therapeutic targets in chordoma.
    Bydon M; Papadimitriou K; Witham T; Wolinsky JP; Bydon A; Sciubba D; Gokaslan Z
    Expert Opin Ther Targets; 2012 Nov; 16(11):1139-43. PubMed ID: 22860993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incipient chordoma: a report of two cases of early-stage chordoma arising from benign notochordal cell tumors.
    Yamaguchi T; Watanabe-Ishiiwa H; Suzuki S; Igarashi Y; Ueda Y
    Mod Pathol; 2005 Jul; 18(7):1005-10. PubMed ID: 15803192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Notochordal tumors: From notochord to chordoma].
    Guinebretière JM; de Pinieux G
    Ann Pathol; 2022 Apr; 42(3):249-258. PubMed ID: 35090767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.